535 related articles for article (PubMed ID: 23973316)
1. Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.
Mota SI; Ferreira IL; Rego AC
Neuropharmacology; 2014 Jan; 76 Pt A():16-26. PubMed ID: 23973316
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of NMDA receptors in Alzheimer's disease.
Zhang Y; Li P; Feng J; Wu M
Neurol Sci; 2016 Jul; 37(7):1039-47. PubMed ID: 26971324
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease.
Paula-Lima AC; Brito-Moreira J; Ferreira ST
J Neurochem; 2013 Jul; 126(2):191-202. PubMed ID: 23668663
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta peptides and glutamatergic synaptic dysregulation.
Parameshwaran K; Dhanasekaran M; Suppiramaniam V
Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990
[TBL] [Abstract][Full Text] [Related]
9. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
Bordji K; Becerril-Ortega J; Buisson A
Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789
[TBL] [Abstract][Full Text] [Related]
10. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
Wenk GL
J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
[TBL] [Abstract][Full Text] [Related]
11. The selective and competitive N-methyl-D-aspartate receptor antagonist, (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid, prevents synaptic toxicity induced by amyloid-β in mice.
Bicca MA; Figueiredo CP; Piermartiri TC; Meotti FC; Bouzon ZL; Tasca CI; Medeiros R; Calixto JB
Neuroscience; 2011 Sep; 192():631-41. PubMed ID: 21756976
[TBL] [Abstract][Full Text] [Related]
12. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
Tu S; Okamoto S; Lipton SA; Xu H
Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
[TBL] [Abstract][Full Text] [Related]
13. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
Koutsilieri E; Riederer P
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
[TBL] [Abstract][Full Text] [Related]
14. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.
Proctor DT; Coulson EJ; Dodd PR
Prog Neurobiol; 2011 Apr; 93(4):509-21. PubMed ID: 21382433
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
Rush T; Buisson A
Cell Tissue Res; 2014 May; 356(2):279-86. PubMed ID: 24496511
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets.
Zádori D; Veres G; Szalárdy L; Klivényi P; Toldi J; Vécsei L
J Alzheimers Dis; 2014; 42 Suppl 3():S177-87. PubMed ID: 24670398
[TBL] [Abstract][Full Text] [Related]
17. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
Cheng X; Wu J; Geng M; Xiong J
Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
